Donor Statin Treatment for Prevention of Severe Acute GVHD After Myeloablative Hematopoietic Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 26 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Aug 2015 Planned primary completion date changed from 1 Jan 2016 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 21 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.